<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/ECF8F3C9-3B3A-43F7-9D68-C558B80BF117"><gtr:id>ECF8F3C9-3B3A-43F7-9D68-C558B80BF117</gtr:id><gtr:name>Motor Neurone Disease Association (MND)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/65A92969-D21B-4A75-808A-3B70F237EEC8"><gtr:id>65A92969-D21B-4A75-808A-3B70F237EEC8</gtr:id><gtr:name>Chronos Therapeutics</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ECF8F3C9-3B3A-43F7-9D68-C558B80BF117"><gtr:id>ECF8F3C9-3B3A-43F7-9D68-C558B80BF117</gtr:id><gtr:name>Motor Neurone Disease Association (MND)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/65A92969-D21B-4A75-808A-3B70F237EEC8"><gtr:id>65A92969-D21B-4A75-808A-3B70F237EEC8</gtr:id><gtr:name>Chronos Therapeutics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F74A7E46-F1D9-421A-BF10-4EFDAD81DFE7"><gtr:id>F74A7E46-F1D9-421A-BF10-4EFDAD81DFE7</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Killick</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/62211B96-56AF-4672-8BA7-754E3F0AC07B"><gtr:id>62211B96-56AF-4672-8BA7-754E3F0AC07B</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>E</gtr:otherNames><gtr:surname>Shaw</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5823B34D-D57E-4D5B-A027-174E28DC4C04"><gtr:id>5823B34D-D57E-4D5B-A027-174E28DC4C04</gtr:id><gtr:firstName>George</gtr:firstName><gtr:surname>Szmukler</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500289"><gtr:id>1FA3B8C3-BBBA-4917-A751-C6F66DDF6188</gtr:id><gtr:title>Centre for Neurodegeneration Research</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500289</gtr:grantReference><gtr:abstractText>We will extend and enhance our current activities which in 2004 included an open day for patients, carers, school students and other interested members of the lay public. We produce a newsletter for participants in one clinical study. Members of the Centre Faculty engage in both print and broadcast media on a regular basis. Further details are described in the main description of the proposed Centre s plans.</gtr:abstractText><gtr:technicalSummary>The understanding of the molecular pathogenesis of neurodegenerative diseases has advanced to such a degree that translation of this research into clinically relevant outcomes is a reality. The mission of the Centre will be to further understand mechanisms of neurodegeneration and to translate this into new treatments, new biomarkers and improved understanding of the signs and symptoms of these diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2011-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2002497</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Motor Neurone Disease Association (MND)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Generation and characterisation of induced pluripotent stem cells from ALS lymphoblasts to model disease pathogenesis and advance drug discovery</gtr:description><gtr:id>D5C9BA2E-9E73-4EF8-933C-2515EAF33814</gtr:id><gtr:impact>Nil yet as just started</gtr:impact><gtr:outcomeId>56d4666230d658.20062502-1</gtr:outcomeId><gtr:partnerContribution>Financial and access to lymphoblast cell lines</gtr:partnerContribution><gtr:piContribution>Research excellence</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eli Lilly &amp; Company Ltd</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Neuroscience Eli Lilly</gtr:department><gtr:description>Identification of compounds that enhance TDP43 clearance in ALS and FTD</gtr:description><gtr:id>6EEB5F19-F0CA-4D1A-88D6-7D6AA21CBFCF</gtr:id><gtr:impact>About to start</gtr:impact><gtr:outcomeId>56d463354455c9.23178454-1</gtr:outcomeId><gtr:partnerContribution>Expertise in drug discovery</gtr:partnerContribution><gtr:piContribution>Identify therapeutic targets for drug discovery</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Motor Neurone Disease Association (MND)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Investigating the role of autophagy and the UPS in TDP-ALS</gtr:description><gtr:id>4E32F5C5-4DA5-463D-B494-DC11A6BB3E2B</gtr:id><gtr:impact>None</gtr:impact><gtr:outcomeId>56d46514219cf7.09918418-1</gtr:outcomeId><gtr:partnerContribution>Financial Support</gtr:partnerContribution><gtr:piContribution>ALS pathobiology</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Medical Research Foundation</gtr:department><gtr:description>From ALS exomes to Functional assays: turning candidates into confirmed genes</gtr:description><gtr:id>7CF1D638-EE97-4D72-BC8E-A5AE23C3C1FB</gtr:id><gtr:impact>None yet as started 5 months ago</gtr:impact><gtr:outcomeId>56d463b5a62d80.69479121-1</gtr:outcomeId><gtr:partnerContribution>financial support</gtr:partnerContribution><gtr:piContribution>Scientific expertise on ALS pathogenesis</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chronos Therapeutics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>RDC5 screen in cellular and animal models of TDP-43 proteinopathy</gtr:description><gtr:id>6E196ECC-83E1-4D75-9F2A-990A3ABCDC3D</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56d464a038b2e9.92331551-1</gtr:outcomeId><gtr:partnerContribution>Compounds to be tested in cellular and animal lmodels</gtr:partnerContribution><gtr:piContribution>ALS pathobiology</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Motor Neurone Disease Association (MND)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Exome sequencing in motor neuron disease: bioinformatic analyses and biological validation of novel variants</gtr:description><gtr:id>680D6CAB-6738-45E0-BADB-638D9A7099D7</gtr:id><gtr:impact>Publication of new ALS genes</gtr:impact><gtr:outcomeId>56d465c83e9ae9.85609946-1</gtr:outcomeId><gtr:partnerContribution>financial</gtr:partnerContribution><gtr:piContribution>ALS research excellence</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit Peterborough</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>C25725F4-2A28-4389-9D02-CE0AA3BA7E4F</gtr:id><gtr:impact>Lectured to school students and informal chat

Enthusiastic discussion</gtr:impact><gtr:outcomeId>BB2D8E9C3C7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient and Carers meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>7673D48D-1174-405A-9487-50280FF1BDAD</gtr:id><gtr:impact>40-60 Patients and Carers lasting 1.5 hours of talk and discussion

Members of the audience are fundraising for a studentship for my laboratory</gtr:impact><gtr:outcomeId>sfMRufTmbZ7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Many media interviews TV, Radio, Newspapers, Radio</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>E69D42DD-92E5-476A-B9BB-2D6116FC74B5</gtr:id><gtr:impact>Many media interviews TV, Radio, Newspapers, Radio

Legislation modified</gtr:impact><gtr:outcomeId>9AE0CB30EDC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centre Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>B1BE2602-0588-43D7-AD1E-800D03B9179D</gtr:id><gtr:impact>Our Open Day is for patients and carers with approximately 150 attendees. We organise 8 laboratory demonstrations presented by PhD students and postdoctoral researchers around which small groups (6-8 persons) circulate. We also have a group of about 12 sixth form students who perform a laboratory experiment. At the end of the day the sixth formers present their results to the who audience and this is followed by an &amp;quot;Any Questions&amp;quot; session with clinical and non-clinical experts answering questions from the visitors.

The Open Day has now been run on three occasions and each time has received universal acclaim from visitors. The report is also made available on our web site.</gtr:impact><gtr:outcomeId>4C98074F446</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presented to Members of Parliament</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>5ABA349D-7509-45D2-8D20-1EEF26D6DA07</gtr:id><gtr:impact>Presented to parliamentary parties

Legeislation changed</gtr:impact><gtr:outcomeId>4945B48396A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient and Carers meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>A7A7BE06-FFFB-4E01-A3F3-EA3B693C9BFA</gtr:id><gtr:impact>Each meeting has 40-60 attendees and lasts 1.5 hours with talk and questions

Patients have come to our laboratory open day and are actively fundraising to create a studentship</gtr:impact><gtr:outcomeId>tGyn6nSUUeL</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Use of Mass Spectrometry for Multi-site Phosphorylation Assays for Tau Protein</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>AEB301BD-58E8-4838-AD0B-7A82B5CE80A5</gtr:id><gtr:impact>Poster presentation at International Conference on Alzheimer's Disease, Chicago

None</gtr:impact><gtr:outcomeId>154D6F59B6C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sleep and circadian rhythm disorder in Parkinson's Disease:  association with hallucinations</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>54421DD3-93A7-4714-A0BD-D5F38D8375C5</gtr:id><gtr:impact>A world conference on sleep.

Received a citation award.</gtr:impact><gtr:outcomeId>0041A34B2A3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Multi-site Phosphorylation Assays for Tau Protein and their relevance to Alzheimer's disease and other neurological disorders</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>2A9AC62A-CE5A-4601-974F-AE68B3CF31AA</gtr:id><gtr:impact>Poster presentation at American Society of Mass Spectrometry conference

None</gtr:impact><gtr:outcomeId>0E3C0190618</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>87502</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MNDA studentship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>AC5998E3-8A77-4EBA-9DE2-6A0D25514154</gtr:id><gtr:outcomeId>pVEA2SfsXd90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Sumission to Parliamentary Science and Technology Committee</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>00EFE38F-7211-4998-9B13-89B1C3C0D3A8</gtr:id><gtr:impact>Permitted the use of hybrid embryos in research in UK</gtr:impact><gtr:outcomeId>E70B2D9560D</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>87522428-1F70-47E1-B6C6-F8DED4CA7C49</gtr:id><gtr:title>Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/648ce689029eb74519bb3610828d1173"><gtr:id>648ce689029eb74519bb3610828d1173</gtr:id><gtr:otherNames>van Eijk RPA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5aa699e5ebbea6.81534669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4435D0E1-0620-4DDC-930B-425C3E1DDD95</gtr:id><gtr:title>Survival of patients with ALS following institution of enteral feeding is related to pre-procedure oximetry: a retrospective review of 98 patients in a single centre.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20254148fbf03c783676652513c094ff"><gtr:id>20254148fbf03c783676652513c094ff</gtr:id><gtr:otherNames>Shaw AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>pm_12421_11_16546754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15D10CD9-7079-49FD-96F1-6097C095F1E0</gtr:id><gtr:title>Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d0493aca288feb1c7b928115cc28a"><gtr:id>a19d0493aca288feb1c7b928115cc28a</gtr:id><gtr:otherNames>De Vos KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12421_11_17725983</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>125E7E79-3735-4917-BB6B-FEE41E98E4CE</gtr:id><gtr:title>Chapter 14 Familial amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a11a5a9f39bc4fcc876c05fec866d8c0"><gtr:id>a11a5a9f39bc4fcc876c05fec866d8c0</gtr:id><gtr:otherNames>Shaw CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>pm_12421_11_18808899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93ECD147-A004-4926-97BE-73A86200D471</gtr:id><gtr:title>Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e078c74958f5d34c29d138c303e544f8"><gtr:id>e078c74958f5d34c29d138c303e544f8</gtr:id><gtr:otherNames>Landers JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>gCYQ71gdCPm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3779DF2B-A01A-41A8-8BFB-C737166026FE</gtr:id><gtr:title>ALSOD: the Amyotrophic Lateral Sclerosis Online Database.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f8ce93db4a227f5353a89a0c28ed415"><gtr:id>3f8ce93db4a227f5353a89a0c28ed415</gtr:id><gtr:otherNames>Wroe R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>7E0D4B624F9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D899CA00-63A0-45FB-A460-FDDC247448E5</gtr:id><gtr:title>Stratified gene expression analysis identifies major amyotrophic lateral sclerosis genes.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/189b1ab3fec05c8e5670388f3356335d"><gtr:id>189b1ab3fec05c8e5670388f3356335d</gtr:id><gtr:otherNames>Jones AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56d46237ac4964.75802103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68926AFF-047F-4993-A25D-79ACF414A763</gtr:id><gtr:title>Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder?</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f2054f5020a7ad7e4cf404fcb230223"><gtr:id>5f2054f5020a7ad7e4cf404fcb230223</gtr:id><gtr:otherNames>Isaacs JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12421_11_17575021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98B48458-5E4F-4EA7-AE62-B82C161826D3</gtr:id><gtr:title>Association study on glutathione S-transferase omega 1 and 2 and familial ALS.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a65b8a61570408253c50561dfcf424a"><gtr:id>5a65b8a61570408253c50561dfcf424a</gtr:id><gtr:otherNames>van de Giessen E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>pm_12421_11_18427999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19E21FA6-18F7-40D7-BFD3-FE83CFA7CF68</gtr:id><gtr:title>Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/260fa42b858aee5033974fabe5a89dd6"><gtr:id>260fa42b858aee5033974fabe5a89dd6</gtr:id><gtr:otherNames>King A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_12421_21_23053136</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CB8F90B-22D0-4E87-908A-536B968B3006</gtr:id><gtr:title>Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d9c6aef0fd3dacfdfaf8caece4d09b8"><gtr:id>1d9c6aef0fd3dacfdfaf8caece4d09b8</gtr:id><gtr:otherNames>Johnston CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_12421_11_17219036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8526EF2-CEDA-4068-B14A-EF6046C7D68D</gtr:id><gtr:title>The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>544bcf013e1c05.46260780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF1FFD05-9CE1-4AAB-8F12-436F749A4175</gtr:id><gtr:title>Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>5aa699e3687533.67844697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFFA9B16-3293-4C70-9C64-42154A5C18B2</gtr:id><gtr:title>H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6883810a16e61c37ff340736f6cdf792"><gtr:id>6883810a16e61c37ff340736f6cdf792</gtr:id><gtr:otherNames>van Rheenen W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_12421_21_23063643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8097A981-0FC0-4513-A2EF-69387787F03C</gtr:id><gtr:title>Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48d87d4a4d6b454c049f981859425ab8"><gtr:id>48d87d4a4d6b454c049f981859425ab8</gtr:id><gtr:otherNames>Rutherford NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>CF450D252AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C53D077-3DFE-4F1E-B456-E5D1F634E28D</gtr:id><gtr:title>No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc23875dbdf591dfec98dd2283598bc3"><gtr:id>cc23875dbdf591dfec98dd2283598bc3</gtr:id><gtr:otherNames>Goris A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>544bcf0257e9b7.52663862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82567C41-178A-414D-9E09-A8D53E0121A3</gtr:id><gtr:title>Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ecfd0497d0375c0a88359b331f4d279"><gtr:id>6ecfd0497d0375c0a88359b331f4d279</gtr:id><gtr:otherNames>Alami NH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>544bcf031799a2.08217536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14340617-FF62-41C2-B646-98B9FC739802</gtr:id><gtr:title>FUS-SMN protein interactions link the motor neuron diseases ALS and SMA.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bf45674c6bde8beb118ae36344c14d8"><gtr:id>9bf45674c6bde8beb118ae36344c14d8</gtr:id><gtr:otherNames>Yamazaki T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_12421_21_23022481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D0AD0D6-5A66-4889-8342-1673BEBB3FCD</gtr:id><gtr:title>Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis?</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c28371205bdf2bb1466dca62f43b2f6"><gtr:id>8c28371205bdf2bb1466dca62f43b2f6</gtr:id><gtr:otherNames>Taylor LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12421_21_23033353</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>289CD27C-2261-4C8F-8EB6-DB74DB6D4267</gtr:id><gtr:title>Comment on &amp;quot;Drug screening for ALS using patient-specific induced pluripotent stem cells&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0033dc734f06165d7061a9236c4adef"><gtr:id>c0033dc734f06165d7061a9236c4adef</gtr:id><gtr:otherNames>Bilican B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>544bcf01f119e7.52699369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9961E591-E8B8-4DED-A0BC-7192B4E510B3</gtr:id><gtr:title>A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac5f45d8a5f9965eb360b3f6697fe0a9"><gtr:id>ac5f45d8a5f9965eb360b3f6697fe0a9</gtr:id><gtr:otherNames>Akimoto C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>544bcf03a36e01.94761814</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5026F3A7-02D2-4287-9873-C405895556EA</gtr:id><gtr:title>TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa1218e77e38a903ec46a6c73ad708a4"><gtr:id>fa1218e77e38a903ec46a6c73ad708a4</gtr:id><gtr:otherNames>Pensato V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56d46239248903.24188323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCC2C6FB-5F45-4079-96C9-A9B147EF0514</gtr:id><gtr:title>Large-scale pathways-based association study in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1bc530dea0f047a0508cb343a8ec2de"><gtr:id>c1bc530dea0f047a0508cb343a8ec2de</gtr:id><gtr:otherNames>Kasperaviciute D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12421_11_17439985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DAFD089-AD4B-4136-8AC0-0F01DCCA818E</gtr:id><gtr:title>A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa2841aab396cd2b4f18a94e7a29ae23"><gtr:id>aa2841aab396cd2b4f18a94e7a29ae23</gtr:id><gtr:otherNames>Morgan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa699e3d49b28.83252519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>813914CE-964F-4F8C-AB2A-461CA615A11D</gtr:id><gtr:title>ALS-FUS pathology revisited: singleton FUS mutations and an unusual case with both a FUS and TARDBP mutation.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/260fa42b858aee5033974fabe5a89dd6"><gtr:id>260fa42b858aee5033974fabe5a89dd6</gtr:id><gtr:otherNames>King A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56d46239d884c7.36960805</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6F77308-0316-40AF-8457-5A4F189068FA</gtr:id><gtr:title>Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56829c73b152e97680b79a2ccde32659"><gtr:id>56829c73b152e97680b79a2ccde32659</gtr:id><gtr:otherNames>Nishimura AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>k9uANyZWPek</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF567BD6-5525-4966-BACD-ECB49B38435E</gtr:id><gtr:title>Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29bb14781cddeeb34ff38065851a6ba1"><gtr:id>29bb14781cddeeb34ff38065851a6ba1</gtr:id><gtr:otherNames>Darovic S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>56d46239a7cf84.98641392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>689F6032-7961-48FF-A618-290E912C9DD0</gtr:id><gtr:title>Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea741f74cf7c60cbe6521035c8abbc4c"><gtr:id>ea741f74cf7c60cbe6521035c8abbc4c</gtr:id><gtr:otherNames>Turner MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>pm_12421_11_18033592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D092A13F-A661-40E4-A8F2-B9F72F076EAB</gtr:id><gtr:title>Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55f1c1d6327fd7a21f6a26807e623513"><gtr:id>55f1c1d6327fd7a21f6a26807e623513</gtr:id><gtr:otherNames>Awasthi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12421_21_21813597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92790017-640C-4AA6-8961-AE67B5353EC9</gtr:id><gtr:title>A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68ae0b5920edebc0579f77ebe7ddbb4e"><gtr:id>68ae0b5920edebc0579f77ebe7ddbb4e</gtr:id><gtr:otherNames>Fogh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>544bcf02883315.60737102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F28E59D5-3FAD-47E8-8231-7A5BAE8E78E2</gtr:id><gtr:title>SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6572db33af98a87af8e9eb68a68a5929"><gtr:id>6572db33af98a87af8e9eb68a68a5929</gtr:id><gtr:otherNames>Wicks P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_12421_11_19252762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACF098C5-64E8-48A0-A91B-BF4C8D42BC24</gtr:id><gtr:title>Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study.</gtr:title><gtr:parentPublicationTitle>Neuroepidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02a3b0ae44952c327deb72e47fcabf9f"><gtr:id>02a3b0ae44952c327deb72e47fcabf9f</gtr:id><gtr:otherNames>Scott KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0251-5350</gtr:issn><gtr:outcomeId>pm_12421_11_19039239</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FBCD51D-2A31-4991-A1BB-CC9E9612BC01</gtr:id><gtr:title>The risk to relatives of patients with sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db7eed95c8d8823c4695be423aefb76b"><gtr:id>db7eed95c8d8823c4695be423aefb76b</gtr:id><gtr:otherNames>Hanby MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12421_21_21933809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B808F8D-C023-4699-B401-3A50303A2BA0</gtr:id><gtr:title>Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d961018c784ae275e4710ba79802b77"><gtr:id>9d961018c784ae275e4710ba79802b77</gtr:id><gtr:otherNames>Tudor EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>cvWfC5garsi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DD07292-EC2D-4508-965D-2B54D92AC960</gtr:id><gtr:title>Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a870ddbc6f40ddea0dc8f5449c90bb5d"><gtr:id>a870ddbc6f40ddea0dc8f5449c90bb5d</gtr:id><gtr:otherNames>Livesey MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>56d4623a8e71d3.84842728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B3ED4F0-E41A-42DF-8308-D0499AF116F2</gtr:id><gtr:title>The sex ratio in amyotrophic lateral sclerosis: A population based study.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d24d309117afa93bba8fc18b9bf0c480"><gtr:id>d24d309117afa93bba8fc18b9bf0c480</gtr:id><gtr:otherNames>Manjaly ZR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>pm_12421_21_20225930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4EA9E98-E40E-448E-9B7F-2C0EC11BBDAC</gtr:id><gtr:title>Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c3f5a5bc7ae9744e72b93546e48cb6f"><gtr:id>7c3f5a5bc7ae9744e72b93546e48cb6f</gtr:id><gtr:otherNames>Ahmeti KB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>544bcf016e38a3.28501419</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC13DAF3-18C7-466F-B795-113834D70D98</gtr:id><gtr:title>p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73513a14720b4cc1a2b1b206959c4d28"><gtr:id>73513a14720b4cc1a2b1b206959c4d28</gtr:id><gtr:otherNames>Al-Sarraj S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>DFqfegzz2TH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39A5379C-D496-4DD2-96A7-2AC54FEFCE27</gtr:id><gtr:title>Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aaff144eb8c549f75ef3e66c1e865ad2"><gtr:id>aaff144eb8c549f75ef3e66c1e865ad2</gtr:id><gtr:otherNames>Mitchell JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_12421_21_22961620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>011CEE4C-3175-47AC-80BF-9E2059910E1E</gtr:id><gtr:title>New VAPB deletion variant and exclusion of VAPB mutations in familial ALS.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e078c74958f5d34c29d138c303e544f8"><gtr:id>e078c74958f5d34c29d138c303e544f8</gtr:id><gtr:otherNames>Landers JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12421_11_18322265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B01549A1-9C4A-4FAA-9B8C-40FA8EDFCE97</gtr:id><gtr:title>VCP mutations are not a major cause of familial amyotrophic lateral sclerosis in the UK.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ca9888509a2e1aa2bdbb5ae3b44a8e0"><gtr:id>4ca9888509a2e1aa2bdbb5ae3b44a8e0</gtr:id><gtr:otherNames>Kwok CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>doi_55f9859851a8bffe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>671D27E6-BFFF-47C5-A1A1-024AC42CA488</gtr:id><gtr:title>Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d024ea21137b0b872fa04d61a2139840"><gtr:id>d024ea21137b0b872fa04d61a2139840</gtr:id><gtr:otherNames>Hortob?gyi T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>ph2tqje8ycQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09EE9498-20E0-46A0-AFD7-8174DAB0F447</gtr:id><gtr:title>Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): a prospective population study.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/287507cf26275f91e2ab1b48dbc45360"><gtr:id>287507cf26275f91e2ab1b48dbc45360</gtr:id><gtr:otherNames>Martin NH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>544bcf034315b5.74043691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDA9A9C2-F6B9-4CEC-A3C2-A86093B4F582</gtr:id><gtr:title>Neurofilament subunit (NFL) head domain phosphorylation regulates axonal transport of neurofilaments.</gtr:title><gtr:parentPublicationTitle>European journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d797bc249bf8a8ae3b3b16815fc8a71f"><gtr:id>d797bc249bf8a8ae3b3b16815fc8a71f</gtr:id><gtr:otherNames>Yates DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0171-9335</gtr:issn><gtr:outcomeId>c4Amwjjc8H4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3611963D-12FF-47BA-B24B-FBEEF81C18A8</gtr:id><gtr:title>Proteome-based plasma biomarkers for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b948558278fbd5ba69e9d363283165b"><gtr:id>6b948558278fbd5ba69e9d363283165b</gtr:id><gtr:otherNames>Hye A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12421_11_17071923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1444E4B8-677A-4F7C-B1EB-635FB793D8B6</gtr:id><gtr:title>An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.</gtr:title><gtr:parentPublicationTitle>Neuropathology : official journal of the Japanese Society of Neuropathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddda41cb956f24e278d3fa4457b83ecb"><gtr:id>ddda41cb956f24e278d3fa4457b83ecb</gtr:id><gtr:otherNames>Troakes C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0919-6544</gtr:issn><gtr:outcomeId>pm_12421_21_22181065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5C3169B-4044-4ACF-AE0E-4DD4D7700499</gtr:id><gtr:title>Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc1ff082016dd34c0b053ded4582c910"><gtr:id>bc1ff082016dd34c0b053ded4582c910</gtr:id><gtr:otherNames>Vivekananda U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12421_21_21551173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C00DE8D-2FC4-4B73-B584-DC6A3DEE0D27</gtr:id><gtr:title>The CHCHD10 P34S variant is not associated with ALS in a UK cohort of familial and sporadic patients.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a1becffcc1571868d22b707ce216d4c"><gtr:id>5a1becffcc1571868d22b707ce216d4c</gtr:id><gtr:otherNames>Wong CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56d462397da5f1.15374831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB70C5E0-F2A4-467D-AE71-F94488DB2573</gtr:id><gtr:title>Evidence of an environmental effect on survival in ALS.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c398b2323889da25d02c67f44bc8075"><gtr:id>4c398b2323889da25d02c67f44bc8075</gtr:id><gtr:otherNames>Keren N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>544bcf0400a993.74066423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50D07D00-E5A8-4F02-B916-9EC594913913</gtr:id><gtr:title>Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0033dc734f06165d7061a9236c4adef"><gtr:id>c0033dc734f06165d7061a9236c4adef</gtr:id><gtr:otherNames>Bilican B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12421_21_22451909</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38B68DBE-0974-42EB-8F96-B5E956480CEE</gtr:id><gtr:title>ATXN2 trinucleotide repeat length correlates with risk of ALS.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdc6e29ff1fbfb82d08db9aa811d9c11"><gtr:id>fdc6e29ff1fbfb82d08db9aa811d9c11</gtr:id><gtr:otherNames>Sproviero W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5aa699e29b59d1.36739737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>341B26E1-6BA6-47F9-962C-323139AAC7D0</gtr:id><gtr:title>Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a885c902c57eeb35d266c592227182d7"><gtr:id>a885c902c57eeb35d266c592227182d7</gtr:id><gtr:otherNames>van Es MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_12421_11_19734901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E53A9D3C-A7DB-4FEE-B72D-C68C8BB46733</gtr:id><gtr:title>Interaction between PON1 and population density in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93dc99c98b59b49150ea537d5c4c070a"><gtr:id>93dc99c98b59b49150ea537d5c4c070a</gtr:id><gtr:otherNames>Diekstra FP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn><gtr:outcomeId>pm_12421_11_19104460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2591FFA0-1FB1-48BE-A44E-6E1529895CF0</gtr:id><gtr:title>Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7bc8538c82db76d6e2482ddeeb2d3d0"><gtr:id>d7bc8538c82db76d6e2482ddeeb2d3d0</gtr:id><gtr:otherNames>Al-Chalabi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>544bcf04de3ed0.40550380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5E26468-4622-43CF-AF76-DE7D7AD2C57D</gtr:id><gtr:title>Unpicking neurodegeneration in a dish with human pluripotent stem cells: one cell type at a time.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0033dc734f06165d7061a9236c4adef"><gtr:id>c0033dc734f06165d7061a9236c4adef</gtr:id><gtr:otherNames>Bilican B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>544bcf0229e0f0.81404388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13C4632E-2D74-4D89-B53F-4643EA5BD113</gtr:id><gtr:title>C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93dc99c98b59b49150ea537d5c4c070a"><gtr:id>93dc99c98b59b49150ea537d5c4c070a</gtr:id><gtr:otherNames>Diekstra FP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>544bcf04854020.50255754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>163BBFFE-3575-4130-A4FA-6BBFD37BBFFA</gtr:id><gtr:title>Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aaff144eb8c549f75ef3e66c1e865ad2"><gtr:id>aaff144eb8c549f75ef3e66c1e865ad2</gtr:id><gtr:otherNames>Mitchell JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56d462387668a0.03122193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32DCAC5A-9E76-4A33-BBD9-1D68743B87A8</gtr:id><gtr:title>VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d0493aca288feb1c7b928115cc28a"><gtr:id>a19d0493aca288feb1c7b928115cc28a</gtr:id><gtr:otherNames>De Vos KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12421_21_22131369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAE2E9D8-48A6-49CC-8339-BFF130C1C449</gtr:id><gtr:title>Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry).</gtr:title><gtr:parentPublicationTitle>Neuroepidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fa948d471e0b6c99da60e79d7cc5fdf"><gtr:id>5fa948d471e0b6c99da60e79d7cc5fdf</gtr:id><gtr:otherNames>Abhinav K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0251-5350</gtr:issn><gtr:outcomeId>pm_12421_11_17898523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66B82633-5886-4031-B03D-AB51CC0A1800</gtr:id><gtr:title>Alexander disease with hypothermia, microcoria, and psychiatric and endocrine disturbances.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3e7348e74b192a401350c369dd08145"><gtr:id>d3e7348e74b192a401350c369dd08145</gtr:id><gtr:otherNames>Sreedharan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12421_11_17438228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D17814CE-6070-4B62-A822-47B756F3D481</gtr:id><gtr:title>Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/107e692c5cbfdd08a4bdfa319afca3cb"><gtr:id>107e692c5cbfdd08a4bdfa319afca3cb</gtr:id><gtr:otherNames>Vance C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>D85B3233FBD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DF9441B-D9E8-4B74-9CEE-44AF383046AF</gtr:id><gtr:title>Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1db640afd979ca29b26d7ca6d657dfcf"><gtr:id>1db640afd979ca29b26d7ca6d657dfcf</gtr:id><gtr:otherNames>M?rotz GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12421_21_22258555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>081FCC73-DA69-4FA2-8FF7-CC35D873DEDA</gtr:id><gtr:title>An evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3108c31a0519408ba70fe51961bbba10"><gtr:id>3108c31a0519408ba70fe51961bbba10</gtr:id><gtr:otherNames>Savage AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>544bcf03736d30.04611140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A708729-8A2A-4D43-B670-A1D63A419EFE</gtr:id><gtr:title>Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a68fd5b1ddbc5cb477a04d8d9b44b0b"><gtr:id>3a68fd5b1ddbc5cb477a04d8d9b44b0b</gtr:id><gtr:otherNames>?talekar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>56d462377e5135.87427190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>267A0B79-058A-404C-B31F-0898CC1898A3</gtr:id><gtr:title>TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3e7348e74b192a401350c369dd08145"><gtr:id>d3e7348e74b192a401350c369dd08145</gtr:id><gtr:otherNames>Sreedharan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_12421_11_18309045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E96F78F-EB09-49F9-8B50-0E46340CFD6E</gtr:id><gtr:title>Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb87f110bb4914af0973f4d8272af1b6"><gtr:id>bb87f110bb4914af0973f4d8272af1b6</gtr:id><gtr:otherNames>Balendra R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>544bcf03ce0f01.11996138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02A18EEE-31CD-4230-9C2B-CF2E220B50CB</gtr:id><gtr:title>Establishing the UK DNA Bank for motor neuron disease (MND).</gtr:title><gtr:parentPublicationTitle>BMC genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d800fe2353c2fd435d4e9f68af2a0c5d"><gtr:id>d800fe2353c2fd435d4e9f68af2a0c5d</gtr:id><gtr:otherNames>Smith L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2156</gtr:issn><gtr:outcomeId>56d462394ec2d4.90473666</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB751689-D983-4126-A98D-F8D038522E72</gtr:id><gtr:title>Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18061332c54aaf54ab04a4a898d17ccc"><gtr:id>18061332c54aaf54ab04a4a898d17ccc</gtr:id><gtr:otherNames>Gomez-Deza J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56d46238c9a2f3.14235257</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44BAFE66-3EE3-4ACF-A574-821A45BB73BC</gtr:id><gtr:title>A common haplotype within the PON1 promoter region is associated with sporadic ALS.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e078c74958f5d34c29d138c303e544f8"><gtr:id>e078c74958f5d34c29d138c303e544f8</gtr:id><gtr:otherNames>Landers JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>pm_12421_11_18618303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB4A3F68-5617-48C7-8E83-5E100F540386</gtr:id><gtr:title>The association between ALS and population density: A population based study.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02a3b0ae44952c327deb72e47fcabf9f"><gtr:id>02a3b0ae44952c327deb72e47fcabf9f</gtr:id><gtr:otherNames>Scott KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>pm_12421_21_20429684</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5E20B58-274E-42B9-9AFB-54143DBC85D2</gtr:id><gtr:title>Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8fd6b166042712fd5babbc67312f707"><gtr:id>b8fd6b166042712fd5babbc67312f707</gtr:id><gtr:otherNames>Taes I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>DX2zb5A6RkF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEAF930E-34A6-4631-BBB5-2290A47B5E0D</gtr:id><gtr:title>Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a7bfa806ecaa3aa93efd2103aa2e758"><gtr:id>0a7bfa806ecaa3aa93efd2103aa2e758</gtr:id><gtr:otherNames>Cirulli ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56d46237448962.78158026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98246C6E-1E09-40FB-B267-C7D0EA11BE9E</gtr:id><gtr:title>A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b676a228ca42acafedbad61b533efdcc"><gtr:id>b676a228ca42acafedbad61b533efdcc</gtr:id><gtr:otherNames>Wills AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12421_11_19321847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1821BCA6-A7B8-4CF2-95C4-6D5E9C2563E3</gtr:id><gtr:title>Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/922738046572c98b4498b0faf60a5115"><gtr:id>922738046572c98b4498b0faf60a5115</gtr:id><gtr:otherNames>van der Kleij LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>56d462384a7143.14080160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73FD8F43-AFBF-4FA6-B9B9-42DC3DCE2816</gtr:id><gtr:title>A proposed staging system for amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6afdab96df90f6df25fd1128f353de57"><gtr:id>6afdab96df90f6df25fd1128f353de57</gtr:id><gtr:otherNames>Roche JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12421_21_22271664</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4406524D-2EEB-4CA0-BDF4-0548FB7E03CB</gtr:id><gtr:title>The role of copy number variation in susceptibility to amyotrophic lateral sclerosis: genome-wide association study and comparison with published loci.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12421_11_19997636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D8E2FA4-3A9A-433E-BC7F-7F85632395B1</gtr:id><gtr:title>Susceptibility genes in sporadic ALS: separating the wheat from the chaff by international collaboration.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a11a5a9f39bc4fcc876c05fec866d8c0"><gtr:id>a11a5a9f39bc4fcc876c05fec866d8c0</gtr:id><gtr:otherNames>Shaw CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12421_11_16966531</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14C8A415-DFC8-4368-A69D-271FE2F37FC8</gtr:id><gtr:title>Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/977dd99e12e9dd5668d74a35223fdb8e"><gtr:id>977dd99e12e9dd5668d74a35223fdb8e</gtr:id><gtr:otherNames>Manser C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>pm_12421_11_18519042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>505D9814-C579-427F-9184-D258D98C9AF7</gtr:id><gtr:title>Screening for OPTN mutations in a cohort of British amyotrophic lateral sclerosis patients.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b92e53040750a2ced7a4b23f1f0a783"><gtr:id>9b92e53040750a2ced7a4b23f1f0a783</gtr:id><gtr:otherNames>Johnson L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_12421_21_22892313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEF32C80-8503-446F-B5DE-F55DABD8D8E2</gtr:id><gtr:title>pNfH is a promising biomarker for ALS.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11fc725be9193e0c1332b674cfa73b21"><gtr:id>11fc725be9193e0c1332b674cfa73b21</gtr:id><gtr:otherNames>Ganesalingam J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>pm_12421_21_23134506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>983024DB-96F7-4EA1-8D90-34DCD64C8BBD</gtr:id><gtr:title>Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c831250c6d5af43302dbd12e99b4fb6"><gtr:id>1c831250c6d5af43302dbd12e99b4fb6</gtr:id><gtr:otherNames>Lee YB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_540e16ae16a8e0adb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E2534AF-447F-441B-B35F-E8F400CBF404</gtr:id><gtr:title>Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/107e692c5cbfdd08a4bdfa319afca3cb"><gtr:id>107e692c5cbfdd08a4bdfa319afca3cb</gtr:id><gtr:otherNames>Vance C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12421_11_16495328</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BA11943-B117-46FE-BBB4-4E81D15394CE</gtr:id><gtr:title>Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c562354aece4404287db767cad69712b"><gtr:id>c562354aece4404287db767cad69712b</gtr:id><gtr:otherNames>Rogelj B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>pm_12421_21_22934129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF4CFB93-2A9D-4E3E-AC8C-B3A9F5F5B7F9</gtr:id><gtr:title>Autosomal dominant inheritance of rapidly progressive amyotrophic lateral sclerosis due to a truncation mutation in the fused in sarcoma (FUS) gene.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4764aa823b7a020b3590bce2cc799303"><gtr:id>4764aa823b7a020b3590bce2cc799303</gtr:id><gtr:otherNames>Kent L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>544bcf045a5fe5.17451079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76ED2AFE-2332-4934-B747-0712FAAA1019</gtr:id><gtr:title>Mushroom-cage gastrostomy tube placement in patients with amyotrophic lateral sclerosis: a 5-year experience in 104 patients in a single institution.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f4cd2d1e64a2ab062b297b332b09cae"><gtr:id>3f4cd2d1e64a2ab062b297b332b09cae</gtr:id><gtr:otherNames>Lewis D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>pm_12421_11_19190913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E993748E-0E7B-442C-92F9-97D3DC665ED4</gtr:id><gtr:title>Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea741f74cf7c60cbe6521035c8abbc4c"><gtr:id>ea741f74cf7c60cbe6521035c8abbc4c</gtr:id><gtr:otherNames>Turner MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_12421_11_17294065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A1E450A-3808-4BD6-B890-E7D50164521B</gtr:id><gtr:title>RNA Misprocessing in-Linked Neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Frontiers in cellular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9adb0cf9c748d2062adf63457cc15ba4"><gtr:id>9adb0cf9c748d2062adf63457cc15ba4</gtr:id><gtr:otherNames>Barker HV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1662-5102</gtr:issn><gtr:outcomeId>5aa699e5738790.24080771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DC7D920-E76D-4C3C-A110-74D246C03324</gtr:id><gtr:title>Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a46cc13f73dd87b9293e1cd22958c7c"><gtr:id>6a46cc13f73dd87b9293e1cd22958c7c</gtr:id><gtr:otherNames>Stepto A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_540e16ae16a979aa1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24B92B9E-ACA0-4C6E-89FA-8808AA3FB26D</gtr:id><gtr:title>The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a2bfcf87c109841d4d8f80742db55e3"><gtr:id>3a2bfcf87c109841d4d8f80742db55e3</gtr:id><gtr:otherNames>Wallace VC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>544bcf04b08166.21868161</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5F9A0FA-0003-478E-B648-A4ED053375A3</gtr:id><gtr:title>Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42186008fbbe7ca8e97d030b07c1ae3d"><gtr:id>42186008fbbe7ca8e97d030b07c1ae3d</gtr:id><gtr:otherNames>Gallois-Montbrun S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>4520E457431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DB9CD58-DED2-4E10-B351-5B647FB84B30</gtr:id><gtr:title>Lack of association between TDP-43 pathology and tau mis-splicing in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52940ec2fe08219598d16e61c9f32c80"><gtr:id>52940ec2fe08219598d16e61c9f32c80</gtr:id><gtr:otherNames>Niblock M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56d4623a192be3.89588407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E472661-D56B-48E3-BA6C-6487E24558A8</gtr:id><gtr:title>Homozygosity analysis in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb5ecebb0a95326732850cb51e132dc6"><gtr:id>bb5ecebb0a95326732850cb51e132dc6</gtr:id><gtr:otherNames>Mok K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>544bcf01c66b68.28467340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3B91679-9EB0-4024-A166-49816A9AD4B0</gtr:id><gtr:title>Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea741f74cf7c60cbe6521035c8abbc4c"><gtr:id>ea741f74cf7c60cbe6521035c8abbc4c</gtr:id><gtr:otherNames>Turner MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12421_11_17420412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4024B02B-C5E5-41CC-846B-297866C47F9A</gtr:id><gtr:title>Novel mutations support a role for Profilin 1 in the pathogenesis of ALS.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5675ddabd33ae</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EFD9E64-39F1-44E4-99D1-2200F5765AC9</gtr:id><gtr:title>The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aa73e328eb61ebd7307a45f0b5976b5"><gtr:id>9aa73e328eb61ebd7307a45f0b5976b5</gtr:id><gtr:otherNames>Martin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>5aa699e4e53521.11586011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>627BF4FA-599E-4D6C-BB65-C674DA3405FF</gtr:id><gtr:title>TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.</gtr:title><gtr:parentPublicationTitle>Neuropathology : official journal of the Japanese Society of Neuropathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0dfa7e2588f19b0ce627ccdbfa75a37"><gtr:id>a0dfa7e2588f19b0ce627ccdbfa75a37</gtr:id><gtr:otherNames>Maekawa S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0919-6544</gtr:issn><gtr:outcomeId>pm_12421_11_19496940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A66F1C3A-7936-46E8-88CB-94FFD9B7F677</gtr:id><gtr:title>The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3617d8d8a839d289a3d354c415cb2d67"><gtr:id>3617d8d8a839d289a3d354c415cb2d67</gtr:id><gtr:otherNames>Lill CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>56d46238134629.13634024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7D74D1E-CD4F-4444-9A2C-718AD0578D8A</gtr:id><gtr:title>Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11fc725be9193e0c1332b674cfa73b21"><gtr:id>11fc725be9193e0c1332b674cfa73b21</gtr:id><gtr:otherNames>Ganesalingam J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>pm_12421_21_21418221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7F50B94-9EF1-4C92-84B7-9105554BD648</gtr:id><gtr:title>CHMP2B mutations are not a common cause of familial or sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9423b3b24e61392d7ea6476d767944a0"><gtr:id>9423b3b24e61392d7ea6476d767944a0</gtr:id><gtr:otherNames>Blair IP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12421_11_18270236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D46E3A28-7400-4BFF-9892-15C79CA78758</gtr:id><gtr:title>Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0737bcb5a8ebef94755f6214dfe82972"><gtr:id>0737bcb5a8ebef94755f6214dfe82972</gtr:id><gtr:otherNames>Tripathi VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>pm_540e16ae16aa32be5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4E1CC76-6492-4495-99F5-73A633C279A2</gtr:id><gtr:title>Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dac006df65aa6fc3664b1b55668fc4f"><gtr:id>9dac006df65aa6fc3664b1b55668fc4f</gtr:id><gtr:otherNames>Simpson CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12421_11_18996918</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DE41022-48D6-448F-ADF9-57550C0FBE02</gtr:id><gtr:title>Mutation analysis of VCP in British familial and sporadic amyotrophic lateral sclerosis patients.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8697d5274b04347d52a7ffa40e09bb2c"><gtr:id>8697d5274b04347d52a7ffa40e09bb2c</gtr:id><gtr:otherNames>Miller JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_12421_21_22789697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91F6DFE4-D709-41B2-BAC7-9671CF3A7DD9</gtr:id><gtr:title>Latent cluster analysis of ALS phenotypes identifies prognostically differing groups.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11fc725be9193e0c1332b674cfa73b21"><gtr:id>11fc725be9193e0c1332b674cfa73b21</gtr:id><gtr:otherNames>Ganesalingam J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12421_11_19771164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99978221-3731-470C-95A3-67CDF5AD5247</gtr:id><gtr:title>Analysis of alternative splicing associated with aging and neurodegeneration in the human brain.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8c5b5cbc90e5661dfa072a51bb8ca2c"><gtr:id>b8c5b5cbc90e5661dfa072a51bb8ca2c</gtr:id><gtr:otherNames>Tollervey JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>pm_12421_21_21846794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE5911A7-0ABF-43DD-8173-DEFA6424AFA4</gtr:id><gtr:title>Advances in tau-based drug discovery.</gtr:title><gtr:parentPublicationTitle>Expert opinion on drug discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6181eaa28be814c0816a3195a16c5e23"><gtr:id>6181eaa28be814c0816a3195a16c5e23</gtr:id><gtr:otherNames>Noble W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1746-0441</gtr:issn><gtr:outcomeId>doi_55f983983a8bf901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E22C5376-8167-4937-8594-D4EB57EE246F</gtr:id><gtr:title>Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f5ee2d92393641a7087d03d8fb52781"><gtr:id>2f5ee2d92393641a7087d03d8fb52781</gtr:id><gtr:otherNames>Scotter EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>544bcf02dec130.64984146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5C9D7A1-5109-41E7-89B0-D311AB53B3AA</gtr:id><gtr:title>Neuromuscular disease: new insights and avenues for therapy.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f5ee2d92393641a7087d03d8fb52781"><gtr:id>2f5ee2d92393641a7087d03d8fb52781</gtr:id><gtr:otherNames>Scotter EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>544bcf019cb4a7.27593700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>954897A3-F1D8-4454-9D89-5779DAEFE00A</gtr:id><gtr:title>Genetic analysis of amyotrophic lateral sclerosis in the Slovenian population.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62f19520245730027ecb4972794f9589"><gtr:id>62f19520245730027ecb4972794f9589</gtr:id><gtr:otherNames>Vrabec K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56d4623a5d1a59.09778202</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25313A0E-69B1-45BA-93E7-98CE1A99B8D9</gtr:id><gtr:title>No association of DPP6 with amyotrophic lateral sclerosis in an Italian population.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68ae0b5920edebc0579f77ebe7ddbb4e"><gtr:id>68ae0b5920edebc0579f77ebe7ddbb4e</gtr:id><gtr:otherNames>Fogh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_12421_11_19525032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92D722BC-0297-4C93-B272-0BD5A3F15313</gtr:id><gtr:title>No evidence for a large difference in ALS frequency in populations of African and European origin: a population based study in inner city London.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b96b5d2bc4235fac5e97640a5503976d"><gtr:id>b96b5d2bc4235fac5e97640a5503976d</gtr:id><gtr:otherNames>Rojas-Garcia R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>pm_12421_21_22214355</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF4282AC-6E90-4FC1-BE4F-BFD4A022F70D</gtr:id><gtr:title>Natural history and clinical features of the flail arm and flail leg ALS variants.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fb43557834c2a82b8da8d59d7d4d211"><gtr:id>9fb43557834c2a82b8da8d59d7d4d211</gtr:id><gtr:otherNames>Wijesekera LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12421_11_19307543</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15A630A7-7ED0-47FB-AEE7-1159D4F926DF</gtr:id><gtr:title>Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93dc99c98b59b49150ea537d5c4c070a"><gtr:id>93dc99c98b59b49150ea537d5c4c070a</gtr:id><gtr:otherNames>Diekstra FP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>544bcf00f13c98.09263733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C78F2DD-5FE3-47AD-B3EA-2C84617FD98A</gtr:id><gtr:title>TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets.</gtr:title><gtr:parentPublicationTitle>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f5ee2d92393641a7087d03d8fb52781"><gtr:id>2f5ee2d92393641a7087d03d8fb52781</gtr:id><gtr:otherNames>Scotter EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1878-7479</gtr:issn><gtr:outcomeId>56d46237093897.21473834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75990AD1-C770-40CC-87CB-9C088A587492</gtr:id><gtr:title>Eating-derived pleasure in amyotrophic lateral sclerosis as a predictor of non-oral feeding.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19df9f5986b30577eb3518d2949da329"><gtr:id>19df9f5986b30577eb3518d2949da329</gtr:id><gtr:otherNames>Johnson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>pm_12421_21_22871077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90ABECCE-64A8-48C0-A5FC-B8F32877C6E5</gtr:id><gtr:title>Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35d6cd3c48df4ba250f8982f7b132101"><gtr:id>35d6cd3c48df4ba250f8982f7b132101</gtr:id><gtr:otherNames>Zimon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12421_21_20460441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD151481-FE5A-4C7B-A651-AF3740F0FC61</gtr:id><gtr:title>ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77bcf36f991f182856eac148a0a0aa02"><gtr:id>77bcf36f991f182856eac148a0a0aa02</gtr:id><gtr:otherNames>Stoica R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>544bcf042f8d38.13230496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B03D4D5F-BB29-43B4-9EA7-021526E29070</gtr:id><gtr:title>Polymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea19fc76f7804dd1a81c51c7e7996ae7"><gtr:id>ea19fc76f7804dd1a81c51c7e7996ae7</gtr:id><gtr:otherNames>Bogaert E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_12421_21_20409611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB2F7890-FE96-4F24-B4C6-4F16B9528B9E</gtr:id><gtr:title>Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddda41cb956f24e278d3fa4457b83ecb"><gtr:id>ddda41cb956f24e278d3fa4457b83ecb</gtr:id><gtr:otherNames>Troakes C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>pm_12421_21_22934812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>736E160D-1754-47BE-A7AB-EE4FB47BC0AC</gtr:id><gtr:title>Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9da89c318f56fc7256d9d74b60d23229"><gtr:id>9da89c318f56fc7256d9d74b60d23229</gtr:id><gtr:otherNames>Sims R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5aa699e46a4a55.51168519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33A59014-0C0D-4C3C-827A-AEB3523D27E9</gtr:id><gtr:title>Birth order and the genetics of amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc1ff082016dd34c0b053ded4582c910"><gtr:id>bc1ff082016dd34c0b053ded4582c910</gtr:id><gtr:otherNames>Vivekananda U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_12421_11_18060566</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500289</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>5191BE6E-A234-4D62-A4F3-B50DBAAE8217</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>4.5  Resources and infrastructure (detection)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>